1. Efficacy and safety of clopidogrel, ticagrelor, and prasugrel in an all-comers population of patients with ST-segment elevation myocardial infarction. (25th November 2020) Authors: Ravn Jacobsen, M; Engstroem, T; Torp-Pedersen, C; Gislason, G; Glinge, C; Holmvang, L; Pedersen, F; Koeber, L; Jabbari, R; Soerensen, R Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Familial clustering of unexplained heart failure - A Danish nationwide cohort study. (19th May 2022) Authors: Glinge, C; Rossetti, S; Bruun Oestergaard, L; Stampe, NK; Ravn Jacobsen, M; Koeber, L; Engstroem, T; Torp-Pedersen, C; Gislason, G; Jabbari, R; Tfelt-Hansen, J Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High bleeding risk in all-comers with ST-segment elevation myocardial infarction and use of P2Y12-inhibitiors. (3rd October 2022) Authors: Jacobsen, M R; Jabbari, R; Engstroem, T; Grove, E L; Glinge, C; Pedersen, F; Holmvang, L; Koeber, L; Torp-Pedersen, C; Maeng, M; Veien, K; Freeman, P; Charlot, M G; Kelbaek, H; Soerensen, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Infarct size following loading with ticagrelor/prasugrel versus clopidogrel in ST-segment elevation myocardial infarction. (25th November 2020) Authors: Sabbah, M; Nepper-Christensen, L; Koeber, L; Eik Hoefsten, D; Aleksov Ahtarovski, K; Goeransson, C; Kyhl, K; Ali Ghotbi, A; Malby Schoos, M; Sadjadieh, G; Kelbaek, H; Loenborg, J; Engstroem, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial. (3rd May 2023) Authors: Bo Kunkel, J; Frydland, M; Duus Holle, S; Kjaergaard, J; Pecini, R; Evi Bang, L; Palm, P; Wiberg, S; Holmvang, L; Engstroem, T; Loenborg, J; Eifer Moeller, J; Hartvig Thomsen, J; Hassager, C; Soeholm, H Journal: European heart journal Issue: Volume 12(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Misclassification rate of the angiographically identified culprit lesion in NSTEMI. (3rd October 2022) Authors: Ekstroem, K; Loenborg, J; Nepper-Cristensen, L; Holmvang, L; Joshi, F R; Iversen, A Z; Madsen, P L; Olsen, N T; Pedersen, F; Soerensen, R; Tilsted, H H; Vejlstrup, N G; Jensen, M R J; Engstroem, T Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P5563Importance of multiple myocardial infarctions in patients with ST-segment elevation myocardial infarction - A cardiac magnetic resonance study. (28th August 2018) Authors: Ekstroem, K; Nepper-Christensen, L; Ahtarovski, K A; Kyhl, K; Goransson, C; Bertelsen, L; Ghotbi, A A; Helqvist, S; Hoefsten, D E; Kelbaek, H; Koeber, L; Schoos, M; Vejlstrup, N; Loenborg, J; Engstroem, T Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prevalence and prognosis of frailty in patients >70 years old with acute coronary syndrome referred to invasive angiography. (3rd May 2023) Authors: Ratcovich, H; Palm, P; Faerch, J; Bang, L; Engstroem, T; Tilsted, H H; Holmvang, L Journal: European heart journal Issue: Volume 12(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Soluble suppression of tumorigenicity associated to post-procedural no-or-slow-reflow phenomenon in ST-elevation myocardial infarction. (3rd October 2022) Authors: Sondergaard, F; Beske, R; Frydland, M; Helgestad, O; Jensen, L O; Holmvang, L; Engstroem, T; Moeller, J E; Hassager, C Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗